PREFERRED ORAL TESTOSTERONE UNDECANOATE THERAPY TO ACHIEVE TESTOSTERONE REPLACEMENT TREATMENT

Title:

PREFERRED ORAL TESTOSTERONE UNDECANOATE THERAPY TO ACHIEVE TESTOSTERONE REPLACEMENT TREATMENT

Document Type and Number:

WIPO Patent Application WO/2022/245933

Kind Code:

A8

Abstract:

The present invention features new testosterone undecanoate (TU) dosing regimens, e.g., for testosterone replacement therapy. The TU may be formulated with phytosterols or phytosterol esters.

Inventors:

DHINGRA OM (US)
BERNSTEIN JAMES (US)

Application Number:

PCT/US2022/029819

Publication Date:

January 26, 2023

Filing Date:

May 18, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MARIUS PHARMACEUTICALS LLC (US)

International Classes:

A61K31/568; A61K47/14; A61P5/26

Attorney, Agent or Firm:

ELLISON, Jeffrey, J. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: SEMI-STABLE NEAR-FIELD ELECTROSPUN SCAFFOLDS AND METHODS OF MAKING AND USING THE SAME

Next Patent: PROTECTIVE COAT WITH RETRACTABLE COLLAR